Company: HRTX
Filing Date: 2025-09-09
Form Type: S-3
Source: 0000950170-25-113830
Chunk: 30

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-09-09
Form: S-3
Chunk 30
---
Summary of Private Placement and Convertible Note Issuance” above. We are registering the shares of Common Stock in order to permit the Selling Stockholders, or their permitted transferees or other successors-in-interest that may be identified in a supplement to this prospectus or, if required, a post-effective amendment to the registration statement of which this prospectus is a part, to offer the shares for resale from time to time. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to our Common Stock. Generally, a person “beneficially owns” shares of our Common Stock if the person has or shares with others the right to vote those shares or to dispose of them, or if the person has the right to acquire voting or disposition rights within 60 days. The second column lists the number of shares of Common Stock beneficially owned by each Selling Stockholder. The third column lists the number of shares of Common Stock being offered by the Selling Stockholders pursuant to this prospectus. The fourth and fifth columns list the number of shares of Common Stock and percentage of our outstanding Common Stock to be held by the Selling Stockholders assuming the sale of all of the shares offered by the Selling Stockholders pursuant to this prospectus.

| Name of Selling Stockholder                                 |     |   Number of 
      Shares 
   of Common 
 Stock Owned 
    Prior to 
    Offering |     |     Maximum 
   Number of 
      Shares 
   of Common 
       Stock 
  to be Sold 
 Pursuant to 
        this 
  Prospectus |     |  Number of 
     Shares 
  of Common 
      Stock 
      Owned 
      After 
   Offering |     | Percentage 
 of Class   
 After the  
 Offering   |
| Entities Affiliated with Rubric Capital Management LP(1)(3) |     |  49,491,272 |     |  22,777,769 |     | 26,713,503 |     | 12.8%      |
| Velan Capital Master Fund LP(2)(4)                          |     |  10,616,301 |     |   2,466,666 |     |  8,149,635 |     | 4.3%       |
| Entities Affiliated with Clearline Capital LP(2)(5)         |     |   9,247,454 |     |   7,999,991 |     |  1,247,